JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Karyopharm Therapeutics Announces Full Exercise of Underwriters' Option to Purchase Additional Shares in Its Initial Public Offering
-
JMP Securities Upgrades Demand Media (DMD) to Market Outperform
-
JMP Securities Starts Springleaf Holdings (LEAF) at Market Outperform
-
JMP Securities Downgrades Actuate Corporation (BIRT) to Market Perform
-
RAIT Financial (RAS) Prices $125M Convertible Notes Offering
-
JMP Securities Starts Motorola Mobility Holdings (MMI) at Market Outperform
-
Notable Analyst Rating Changes 12/03: (ABBV) (AAPL) (FRX) Upgraded; (PFE) (DIS) (AT) Downgraded
-
JMP Securities Starts New York Mortgage Trust (NYMT) at Market Perform
-
JMP Securities Downgrades Myriad Genetics (MYGN) to Market Perform
-
Notable Analyst Rating Changes 12/02: (RKUS) (AEO) (EBAY) Upgraded; (MMM) (GRPN) (XL) Downgraded
-
JMP Securities Starts LGI Homes (LGIH) at Market Outperform
-
JMP Securities Starts Barracuda Networks (CUDA) at Market Outperform
-
JMP Securities Starts Karyopharm Therapeutics (KPTI) at Market Outperform
-
Pre-Open Stock Movers 11/29: (ZOOM) (FRO) (UPIP) Higher; (UEPS) (THOR) (IPCI) Lower (more...)
-
Organovo (ONVO) May Offer 4M Shares of Common Stock, Filing Shows
-
JMP Securities Upgrades National Health Investors (NHI) to Market Outperform
-
Cardiovascular Systems (CSII) Prices 2.6M Common Offering at $30/Share
-
SPS Commerce (SPSC) Prices 750K Offering at $67/Share
-
Notable Mergers and Acquisitions of the Day 11/19: (NCT) (AZN)/(HZNP) (SWM) (UFS)
-
Horizon Pharma (HZNP) to Acquire VIMOVO U.S. Rights from AstraZeneca (AZN)
-
SPS Commerce (SPSC) Plans 750K Common Offering
-
Cardiovascular Systems (CSII) Announces 2.1M Common Stock Offering
-
Synta Pharma (SNTA) Closes 16.1M Common Offering at $3.75/Share
-
JMP Securities Starts Essent Group (ESNT) at Market Outperform
-
Synta Pharmaceuticals (SNTA) Prices 14M Share Offering at $3.75
-
Chelsea Therapeutics (CHTP) Prices 6.67M Common Offering at $3/Share
-
JMP Securities Downgrades Silver Bay Realty Trust Corp. (SBY) to Market Perform
-
LGI Homes (LGIH) IPO Trades Handsomely Higher
-
Karyopharm Therapeutics (KPTI) IPO Opens Higher
-
Barracuda Networks (CUDA) IPO Opens Sharply Higher
-
JMP Securities Starts Horizon Technology Finance (HRZN) at Market Perform
-
JMP Securities Starts LDR Holding (LDRH) at Market Outperform
-
Tetraphase Pharma (TTPH) Announces 3.3M Common Stock Offering
-
Marcus & Millichap (MMI) IPO Opens Higher
-
Tableau Software (DATA) Announces Proposed Secondary Offering
-
JMP Securities Starts Independence Realty Trust (IRT) at Market Outperform
-
JMP Group (JMP) Tops Q3 EPS by 2c
-
JMP Securities Starts TCP Capital (TCPC) at Market Outperform
-
JMP Securities Starts Auxilium Pharmaceuticals (AUXL) at Market Outperform
-
Mazor Robotics (MZOR) Announces 2M ADS Offering; Updates on YTD Performance
-
Notable Analyst Rating Changes 10/16: (INTC) (S) (JNPR) Upgraded; (VVUS) (ELLI) (ACI) Downgraded
-
JMP Securities Starts Triangle Capital (TCAP) at Market Perform
-
JMP Securities Downgrades Ellie Mae (ELLI) to Market Perform
-
JMP Securities Starts BIND Therapeutics (BIND) at Market Outperform
-
Notable Analyst Rating Changes 10/14: (ALU) (LINTA) (THOR) Upgraded; (EXPE) (MYL) (MRK) Downgraded
-
JMP Securities Starts Acceleron Pharma (XLRN) at Market Outperform
-
JMP Securities Upgrades Total System Services (TSS) to Market Outperform
-
Aratana Therapeutics (PETX) to Acquire Vet Therapeutics in Cash, Stock Deal
-
Notable Analyst Rating Changes 10/10: (DFS) (HPQ) (SSYS) Upgraded; (ARIA) (RT) (HUBG) Downgraded
-
JMP Securities Downgrades ARIAD Pharmaceuticals (ARIA) to Market Perform

